Microscopic Polyangiitis clinical trials
The registry lists 63 studies for Microscopic Polyangiitis across more than 10 countries. 11 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-04.
Status
- Completed
- 34
- Recruiting
- 10
- Terminated
- 7
- Status unknown
- 6
- Active, not recruiting
- 4
- Not yet recruiting
- 1
Phase
- Phase 2
- 16
- Phase 3
- 14
- Phase 4
- 9
- Phase 1
- 4
Where
- United States
- 30
- France
- 18
- Canada
- 16
- United Kingdom
- 15
- Germany
- 7
- Italy
- 7
Who runs them
Assistance Publique - Hôpitaux de Paris (10) · University of Pennsylvania (8) · University of South Florida (5) · Cambridge University Hospitals NHS Foundation Trust (4) · Mayo Clinic (2) · Novartis Pharmaceuticals (2) · Hoffmann-La Roche (2) · University of Oxford (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 63 — search for more.
- Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic DiseasesRecruitingNCT07087912Phase 41 country
- Ocular Manifestations of Granulomatosis With Polyangiitis.RecruitingNCT076647091 country
- Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive Rituximab Treatment in Cases of ANCA Reappearance in Granulomatosis With Polyangiitis and Microscopic Polyangiitis.Not yet recruitingNCT07451847Phase 41 country
- Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)RecruitingNCT06983821Phase 31 country
- Vasculitis Pregnancy RegistryRecruitingNCT025935651 country
- Clinical Transcriptomics in Systemic Vasculitis (CUTIS)RecruitingNCT030043262 countries
- VCRC Tissue RepositoryRecruitingNCT029670682 countries
- One-Time DNA Study for VasculitisRecruitingNCT012413053 countries
- Special Drug Use-results Survey for Long-term Use（Avacopan）RecruitingNCT067582711 country
- Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)RecruitingNCT06350110Phase 1/21 country
- Pediatric Vasculitis InitiativeRecruitingNCT020061347 countries
- Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPAActive, not recruitingNCT06868290Phase 28 countries
- Iptacopan in Patients With ANCA Associated VasculitisActive, not recruitingNCT06388941Phase 215 countries
- Soluble CD95 Ligand Role in the Pathophysiology of Antineutrophil Cytoplasmic Antibody (ANCA) Associated VasculitisCompletedNCT03698071Not applicable1 country
- PR3-AAV Resilient Remission or PRRRTerminatedNCT05376319Phase 21 country
- Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic PolyangiitisCompletedNCT03920722Phase 31 country
- Hydroxychloroquine in ANCA Vasculitis EvaluationTerminatedNCT04316494Phase 41 country
- Low Dose Naltrexone to Improve Physical Health in Patients With VasculitisCompletedNCT03482479Phase 22 countries
- Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the OriginatorCompletedNCT057163341 country
- Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)Active, not recruitingNCT06294236Phase 11 country
- Efficacy Study of Two Treatments in the Remission of VasculitisCompletedNCT00748644Phase 31 country
- Comparison Between a Long Term and a Conventional Maintenance Treatment With RituximabCompletedNCT02433522Phase 31 country
- Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase AntibodiesCompletedNCT03385668Phase 21 country
- An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular DiseasesActive, not recruitingNCT05732402Phase 1/24 countries
- Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)CompletedNCT018620681 country
- Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)CompletedNCT00647166Phase 31 country
- Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated VasculitisCompletedNCT01731561Phase 31 country
- Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)CompletedNCT00103792Phase 31 country
- Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia.CompletedNCT057038021 country
- PRagmatic Analysis of Vitamin D in ANCA-Associated VasculitisCompletedNCT04280601Not applicable1 country
- Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.CompletedNCT03895801Phase 211 countries
- Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic PolyangiitisCompletedNCT003153932 countries
- A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic PolyangitisCompletedNCT02115997Phase 41 country
- Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPATerminatedNCT03712345Phase 22 countries
- Rituximab Vasculitis Maintenance StudyCompletedNCT01697267Phase 310 countries
- Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated VasculitisCompletedNCT02169219Phase 41 country
- Low-dose Glucocorticoid Vasculitis Induction StudyStatus unknownNCT02198248Phase 41 country
- Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated VasculitisTerminatedNCT024748881 country
- Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated VasculitisCompletedNCT00987389Phase 315 countries
- VCRC Patient Contact Registry Patient-Reported Data Validation StudyCompletedNCT021909421 country
- A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic PolyangiitisCompletedNCT01750697Phase 28 countries
- An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic PolyangiitisCompletedNCT016135991 country
- Journey of Patients With Vasculitis From First Symptom to DiagnosisCompletedNCT034102901 country
- Belimumab in Remission of VASculitisCompletedNCT01663623Phase 320 countries
- Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up StudyTerminatedNCT015868582 countries
- The ANCA Vasculitis Questionnaire (AAV-PRO©)CompletedNCT025070241 country
- Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic PolyangiitisCompletedNCT00104299Phase 2/32 countries
- American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic VasculitisStatus unknownNCT0106620833 countries
- Impact of Vasculitis on Employment and IncomeCompletedNCT024762921 country
- BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel VasculitisWithdrawnNCT01598857Phase 2